Hyperthermo-chemo-radiotherapy for carcinoma of the esophagus.
Hyperthermo-chemo-radiotherapy was prescribed preoperatively for eight patients with carcinoma of the esophagus. Histological study of the resected specimens showed marked effect in two, moderate effect in four and slight effect in two. In those with marked effect, there were no viable neoplastic cells, and severe necrosis and complete destruction were evident on the mucosal surface. These two patients have had no recurrence, now at 27th and 31st postoperative months. Those findings suggest that hyperthermo-chemo-radiotherapy is effective for selected patients with carcinoma of the esophagus.
D000368:Aged; D001761:Bleomycin / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000628:therapy*; D004944:Esophagoplasty; D005260:Female; D006358:Hot Temperature / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011867:Radioisotope Teletherapy
D003037:Cobalt Radioisotopes; D001761:Bleomycin